The vitamin folic acid, emerged as an almost ideal targeting agent for imaging purposes and therapy of cancer and inflammatory diseases because of the very high affinity (KD < 10−9 M) to both, the FR-α and the FR-β and because of its non-toxic and non-immunogenic properties [22]. Here, FOLR2 is linked to cancer.